High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy

High viral load predicts virologic failure in chronic genotype 2 hepatitis C virus-infected patients receiving glecaprevir/pibrentasvir therapy

Background: The real-world data of glecaprevir/pibrentasvir (GLE/PIB) therapy for patients with chronic hepatitis C virus (HCV) genotype 2 infection remained limited. We aimed to evaluate the possible predictors of virological failure and side effects of GLE/PIB therapy for chronic genotype 2 HCV-in...

Full description

Bibliographic Details
Main Authors: Wei-Ming Chen, Kuo-Liang Wei, Shui-Yi Tung, Chien-Heng Shen, Te-Sheng Chang, Chih-Wei Yen, Yung-Yu Hsieh, Wen Nan Chiu, Jin Hung Hu, Sheng-Nan Lu, Chao-Hung Hung
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Journal of the Formosan Medical Association
Subjects:
Glecaprevir/pibrentasvir
Hepatitis C virus
Sustained viral response
Virological failure
Pruritus
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664620303843

Internet

http://www.sciencedirect.com/science/article/pii/S0929664620303843

Similar Items